PEC vs Ever Supreme Bio Technology: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and Ever Supreme Bio Technology (6712) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ Ever Supreme Bio Technology

0%+108%+0%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYEver Supreme Bio TechnologyYoY
Oct 2026NT$2.84 billion+102.0%NT$112.1 million+0.8%
Sep 2026NT$2.64 billion+100.0%NT$110.5 million+21.3%
Aug 2026NT$2.62 billion+105.4%NT$109.6 million+21.1%
Jul 2026NT$2.51 billion+92.6%NT$99.2 million+20.7%
Jun 2026NT$2.33 billion+94.9%NT$93.9 million+16.1%
May 2026NT$2.46 billion+108.5%NT$90.6 million+25.0%
Apr 2026NT$2.06 billion+68.3%NT$85.2 million+26.2%
Mar 2026NT$1.94 billion+64.4%NT$70.1 million+15.1%
Feb 2026NT$1.6 billion+56.7%NT$62.2 million+3.4%
Jan 2026NT$1.58 billion+49.8%NT$58.2 million+2.4%
Dec 2025NT$1.92 billion+69.9%NT$128 million+0.7%
Nov 2025NT$1.55 billion+53.0%NT$125 million+1.3%
Oct 2025NT$1.4 billion+53.6%NT$111.1 million+12.2%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16